Schizophrenia affects about 1% of the population. It is poorly characterized. A pathway model of disruption offers a good tool to observe network-wide disruptions. Here, we use PathLinker to link hand-curated receptors and transcription factors, and combine the resulting networks into metanetworks. Topologically, schizophrenia pathways were found to not have significantly more node overlap than a random sampling, but were found to have significantly more edge overlap (p = 0.0661, p < 0.0001). PathLinker reconstructed well-known signaling proteins, proteins known to be associated with schizophrenia, and neuronal proteins not previously studied in a schizophrenia context.
INTRODUCTION
Schizophrenia is a highly heterogeneous and poorly characterized disorder. In heterogeneous diseases, genetic risk is passed down through a large number of alleles, ranging from common, small effect alleles to rare de novo mutations with large effects, which are very difficult to discover using a genomic approach.
Genomic studies have yielded several genes that contribute to the heritable risk of schizophrenia [2] . However, they are limited by the "long tail" phenomenon, which statistically makes the discovery of rare but collectively frequent mutations difficult. Instead, a pathway analysis could be used to more accurately model the disruption of physiological processes in schizophrenia.
Neurons, like all cells, communicate through a process called signal transduction. Cell-cell signaling typically begins at a receptor, and proceeds through a series of protein interactions until it reaches a transcription factor, which can activate or deactivate a particular gene's expression. This can include dozens to hundreds of proteins.
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We use PathLinker, an algorithm that reconstructs signaling pathways from protein-protein interactomes, to build signaling pathways potentially disrupted in schizophrenia. We input receptors and transcription factors known to be associated with schizophrenia, and analyze the topology of the resulting networks using node overlap percentages. From here, we create metanetworks based on distance, and qualitatively observe the resulting proteins forming the paths between chosen receptors and transcription factors.
METHODS

PathLinker.
We are given a directed graph G = (V, E) describing an interactome, where nodes represent proteins and edges represent interactomes among proteins. The interactome G has an associated cost for each edge e ∈ E [3] . Given a source set of nodes S ⊆ V and a target set of nodes T ⊆ V , Pathlinker efficiently calculates the k shortest paths from any source node in S to any target node in T [4] .
In this work, we run PathLinker using iterative pairs of targets and receptors; i.e., for every receptor in the source set S = s1, s2, ...sx and every transcription factor in the target set T = t1, t2, ...ty, PathLinker computed the k=100 paths between each possible pair (sx, ty).
Datasets.
Sources and targets were hand-curated from the literature. Receptors were chosen as sources if they were significantly associated with schizophrenia etiology, either directly through GWAS significance or gene expression data, or indirectly due to association with a neurotransmitter whose metabolism was known to be disrupted in schizophrenia. Receptors that are known drug targets were also selected, namely, D2 and nicotinic acetylcholine receptors. Additionally, the receptor list was expanded to include receptor families, most or all subunits of receptors, and select isoforms, in order to broaden the possible interactions in the incomplete interactome. This yielded 48 receptors.
Five transcription factors were similarly chosen from the literature, either because they were significantly associated in the GWAS or were known to regulate a gene that was significantly associated with schizophrenia [2] .
We use the same interactome G as is described in [4] , comprised from numerous protein-protein interaction and signaling databases. 
RESULTS
From the 48 x 5 possible pairs of receptors and transcription factors, PathLinker generated 170 networks of 100 paths each. Several sources were absent from the interactome.
We calculated the node overlap between all pairs of the 170 networks and clustered them using the scipy hierarchical clustering package in Python (Figure 1) . We find that subsets of networks have similar nodes, despite different receptor/transcription factor pair. We combined each cluster of networks with a similarity score of 2 or better into metanetworks and visualized these metanetworks in an interactive graph visualization tool called GraphSpace.
PathLinker reconstructed several well-known signaling proteins, including G-coupled proteins and MAPK complexes. Several key proteins from the resulting pathways were then analyzed through a literature search. Several proteins had published literature linking them to schizophrenia literature, and others had no published literature that showed that they had been studied in a schizophrenia context, making them good candidates for future study.
For example, Figure 2 shows GNG, GNA, and GNB families, which are all G-protein coupled receptors, well-known to be involved in signaling. PIK3R1 is known to be implicated in bipolar disorder and schizophrenia [1] , and ABL1 has not been studied in a schizophrenia context, but has been implicated with neuronal death and inflammation in mice forebrains [5] .
Finally, we compared the heatmaps to PathLinker results on a random sample of receptor/transcription factor pairs. Schizophrenia pathways were found to not have significantly more node overlap than a random sampling (p=0.0661, student's t-test), but were found to have significantly more edge 
CONCLUSIONS
Network analysis offers a powerful tool to use in conjunction with genomic results. This method successfully reconstructs well-known signaling pathways, proteins known to be involved in schizophrenia etiology, and offers good hypotheses for future molecular physiology studies.
